What is Dezhan Healthcare Company Limited's (000813.SZ) StockRank?

MoatMap's StockRank for Dezhan Healthcare Company Limited (000813.SZ) is 42/100, with a Hold signal. This is a composite score combining Quality (45), Value (45), and Momentum (44) factor ranks across MoatMap's 19,000+ stock universe.

Does Dezhan Healthcare Company Limited have an economic moat?

Dezhan Healthcare Company Limited (000813.SZ) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Dezhan Healthcare Company Limited a buy, hold, or sell?

MoatMap's current signal for Dezhan Healthcare Company Limited (000813.SZ) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Dezhan Healthcare Company Limited in?

Dezhan Healthcare Company Limited (000813.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000813.SZ

HOLDREMOVE

Dezhan Healthcare Company Limited · Healthcare · China · $1.0B · Avg Vol: $24M/d

StockRank

P/E (TTM)

—

ROE

-9.0%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Dezhan Healthcare lacks the scale, regulatory moat, and global footprint required to capitalize on the CDMO pricing power cycle, making it a low-conviction play in a highly fragmented domestic market.

COMPANY DESCRIPTION

Dezhan Healthcare Company Limited is a pharmaceutical enterprise primarily focused on the research, development, and sale of cardiovascular drugs, notably its flagship generic atorvastatin calcium tablets. The company leverages its established clinical sales network and low-cost manufacturing capabilities to maintain a strong position in China's centralized drug procurement market. It is actively diversifying its portfolio into oncology therapeutics, peptide cosmetics, and medical cannabis applications.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	84M	74M	69M	59M	-11.4%
EPS	-0.00	0.01	-0.00	-0.02	—
Shares	2.2B	2.2B	2.2B	2.1B	-5.8%
Debt	1M	1M	3M	20M	145.8%
Equity	782M	774M	762M	685M	-4.3%
Op CF	24M	19M	-2M	697,952	-69.2%
Inv CF	149M	26M	-27M	-101M	—
Fin CF	-7M	-24M	-12M	-3M	—

PRICE (1M)-18.5%

SMA 50SMA 200

$0.45

RSI (14)

33.7

52W High

$0.78

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-8.9%35.4

ROE

-9.0%36.1

GP/Assets

4.1%17.0

Op. Margin

-54.0%20.7

FCF/Assets

-5.1%35.7

Piotroski

—55.8

Int. Cover

-50.0x6.5

D/E Ratio

0.03x78.8

Current Ratio

16.69x93.5

Value

P/E (TTM)

—N/A

EV/EBITDA

-46.0x92.9

P/FCF

—N/A

P/B

1.4x68.4

P/S

16.3x19.3

Div Yield

—N/A

Momentum

52W High %

58%36.0

RS 6M

-32%39.4

SMA 50/200

0.89x32.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—94.4

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$1.0B

P/E (Forward)

6.0x

Gross Margin

49.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000813.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
000813.SZ	Dezhan Healthcare Company Limited(you)	$1.0B	42	HOLD
600488.SS	Tianjin Tianyao Pharmaceuticals Co., Ltd.	$894M	40	HOLD
300026.SZ	Tianjin Chase Sun Pharmaceutical Co.,Ltd	$1.4B	43	HOLD
002675.SZ	Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	$1.6B	43	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
300267.SZ	Hunan Er-Kang Pharmaceutical Co., Ltd	$1.1B	34	SELL
300194.SZ	Fuan Pharmaceutical (Group) Co., Ltd.	$672M	43	HOLD
600829.SS	HPGC Renmintongtai Pharmaceutical Corporation	$746M	46	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Dezhan Healthcare Company Limited (000813.SZ) — Stock Score Summary

Dezhan Healthcare Company Limited (000813.SZ) has a MoatMap StockRank of 42/100 based on Quality (45/100), Value (45/100), and Momentum (44/100) factor scores. The current signal is HOLD. Dezhan Healthcare lacks the scale, regulatory moat, and global footprint required to capitalize on the CDMO pricing power cycle, making it a low-conviction play in a highly fragmented domestic market.

Key Financial Metrics

Price	$0.45
Market Cap	$1.0B
P/E (Forward)	6.02
Price/Book	1.40
Return on Equity	-9.0%
Return on Invested Capital	-8.9%
Debt/Equity	2.93
Gross Margin	49.6%
Operating Margin	-54.0%
Revenue Growth	-0.7%
Free Cash Flow	$-5M

Dezhan Healthcare Company Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Dezhan Healthcare Company Limited’s (000813.SZ) StockRank?: MoatMap’s StockRank for Dezhan Healthcare Company Limited (000813.SZ) is 42/100, with a Hold signal. It is a composite of Quality (45), Value (45), and Momentum (44) factor ranks across MoatMap’s 19,000+ stock universe.
Does Dezhan Healthcare Company Limited have an economic moat?: Dezhan Healthcare Company Limited (000813.SZ) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Dezhan Healthcare Company Limited a buy, hold, or sell?: MoatMap’s current signal for Dezhan Healthcare Company Limited (000813.SZ) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Dezhan Healthcare Company Limited in?: Dezhan Healthcare Company Limited (000813.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).